|
|
|
PUBLIKATIONEN
|
ORIGINAL- UND ÜBERSICHTSARBEITEN
|
| 1. |
Hartter E, Weissel M, Stummvoll HK, Woloszczuk W, Punzengruber C, Ludvik B: Atrial natriuretic peptide concentrations in blood from right atrium in patient with severe right heart failure. Lancet 2:93-94, 1985 |
| 2. |
Weissel M, Punzengruber C, Hartter E, Ludvik B, Woloszczuk W: Thyroid hormones and pericardial effusion may influence plasma levels of atrial natriuretic peptide (ANP) in humans. Klin.Wochenschr. 64 Suppl 6:93-96, 1986 |
| 3. |
Woloszczuk W, Ludvik B: Nachweis und radioimmunologische Quantifizierung von humanem atrialen natriuretischen Peptid im Harn. Berichte der ÖGKC 9:65-67, 1986 |
| 4. |
Punzengruber C, Hartter E, Weissel M, Burghuber OC, Ludvik B, Woloszczuk W: [Peripheral and right atrial plasma levels of atrial natriuretic peptide and their relation to mean atrial pressure]. Z.Kardiol. 76:72-75, 1987 |
| 5. |
Ludvik B, Niederle B, Roka R, Schernthaner G, Neuhold N: [Malignant aldosteronoma in the differential diagnosis of Conn syndrome]. Acta Med.Austriaca 15:117-120, 1988 |
| 6. |
Hay U, Ludvik B, Gisinger C, Schernthaner G: [Lack of effect of ACE inhibition on severe proteinuria in diabetic nephropathy--a 6-month-long study]. Schweiz.Med.Wochenschr. 118:165-169, 1988 |
| 7. |
Wrba F, Chott A, Ludvik B, Schratter M, Spona J, Reiner A, Schernthaner G, Krisch K: Solid and cystic tumour of the pancreas; a hormonal-dependent neoplasm? Histopathology 12:338-340, 1988 |
| 8. |
Wrba F, Chott A, Schratter M, Ludvik B, Krisch K, Holzner JH: [Fine-needle puncture cytology of a solid cystic tumor of the pancreas]. Pathologe 9:340-344, 1988 |
| 9. |
Ludvik B, Scheithauer W, Wrba F, Schratter M, Schiessel R, Schernthaner G: [Gestagen receptor-positive, solid-cystic acinar-cell tumor of the pancreas]. Dtsch.Med.Wochenschr. 114:903-906, 1989 |
| 10. |
Hartter E, Svoboda T, Lell B, Schuller M, Ludvik B, Woloszczuk W, Prager R: Reduced islet-amyloid polypeptide in insulin-dependent diabetes mellitus. Lancet 335:854, 1990 |
| 11. |
Graf H, Watzinger U, Ludvik B, Wagner A, Hocker P, Zweymuller KK: Recombinant human erythropoietin as adjuvant treatment for autologous blood donation. BMJ 300:1627-1628, 1990 |
| 12. |
Ludvik B, Kueenburg E, Brunnbauer M, Schernthaner G, Prager R: The effects of ramipril on glucose tolerance, insulin secretion, and insulin sensitivity in patients with hypertension. J.Cardiovasc.Pharmacol. 18 Suppl 2:S157-S159, 1991 |
| 13. |
Prager R, Ludvik B, Hartter E: [Role of amylin in the pathogenesis of type II diabetes mellitus]. Acta Med.Austriaca 18:61-62, 1991 |
| 14. |
Ludvik B, Peer G, Berzlanovich A, Stifter S, Graf H: Effects of dichloroacetate and bicarbonate on haemodynamic parameters in healthy volunteers. Clin.Sci.(Colch.) 80:47-51, 1991 |
| 15. |
Hartter E, Svoboda T, Ludvik B, Schuller M, Lell B, Kuenburg E, Brunnbauer M, Woloszczuk W, Prager R: Basal and stimulated plasma levels of pancreatic amylin indicate its co- secretion with insulin in humans. Diabetologia 34:52-54, 1991 |
| 16. |
Ludvik B, Lell B, Hartter E, Schnack C, Prager R: Decrease of stimulated amylin release precedes impairment of insulin secretion in type II diabetes. Diabetes 40:1615-1619, 1991 |
| 17. |
Ludvik B, Kautzky-Willer A, Prager R: Epidemiologie: Ätiologie und neue therapeutische Konzepte bei Adipositas. Therapiewoche Österreich 7:14-19, 1992 |
| 18. |
Kautzky-Willer A, Pacini G, Ludvik B, Schernthaner G, Prager R: Beta-cell hypersecretion and not reduced hepatic insulin extraction is the main cause of hyperinsulinemia in obese nondiabetic subjects. Metabolism 41:1304-1312, 1992 |
| 19. |
Ludvik B, Niederle B, Roka R, Neuhold N, Templ M, Schernthaner G: Isolated primary hyperaldosteronism in adrenocortical carcinoma. Acta Chirurgica Austriaca 25:212-216, 1993 |
| 20. |
Ludvik B, Stifter S, Hartter E, Capek M, Prager R, Graf H: Accresciutti livelli del polipeptide amiloide delle isole non hanno effetto sulla secrezione di insulina in pazienti con danno renale cronico. Giornale italiano di Diabetologia 12:204-205, 1993 |
| 21. |
Ludvik B, Clodi M, Kautzky-Willer A, Capek M, Hartter E, Pacini G, Prager R: Effect of dexamethasone on insulin sensitivity, islet amyloid polypeptide and insulin secretion in humans. Diabetologia 36:84-87, 1993 |
| 22. |
Kautzky-Willer A, Pacini G, Weissel M, Capek M, Ludvik B, Prager R: Elevated hepatic insulin extraction in essential hypertension. Hypertension 21:646-653, 1993 |
| 23. |
Ludvik B, Mayer G, Stifter S, Putz D, Barnas U, Graf H: Effects of dichloroacetate on exercise performance in healthy volunteers. Pflugers Arch. 423:251-254, 1993 |
| 24. |
Kautzky-Willer A, Thomaseth K, Pacini G, Clodi M, Ludvik B, Streli C, Waldhausl W, Prager R: Role of islet amyloid polypeptide secretion in insulin-resistant humans. Diabetologia 37:188-194, 1994 |
| 25. |
Ludvik B, Clodi M, Kautzky-Willer A, Schuller M, Graf H, Hartter E, Pacini G, Prager R: Increased levels of circulating islet amyloid polypeptide in patients with chronic renal failure have no effect on insulin secretion. J.Clin.Invest 94:2045-2050, 1994 |
| 26. |
Nolan JJ, Ludvik B, Beerdsen P, Joyce M, Olefsky J: Improvement in glucose tolerance and insulin resistance in obese subjects treated with troglitazone. N.Engl.J.Med. 331:1188-1193, 1994 |
| 27. |
Capek M, Schnack C, Ludvik B, Kautzky-Willer A, Banyai M, Prager R: Effects of captopril treatment versus placebo on renal function in type 2 diabetic patients with microalbuminuria: a long-term study. Clin.Investig. 72:961-966, 1994 |
| 28. |
Kautzky-Willer A, Pacini G, Barnas U, Ludvik B, Streli C, Graf H, Prager R: Intravenous calcitriol normalizes insulin sensitivity in uremic patients. Kidney Int. 47:200-206, 1995 |
| 29. |
Ludvik B, Nolan JJ, Roberts A, Baloga J, Joyce M, Bell JM, Olefsky JM: A noninvasive method to measure splanchnic glucose uptake after oral glucose administration. J.Clin.Invest 95:2232-2238, 1995 |
| 30. |
Ludvik B, Nolan JJ, Baloga J, Sacks D, Olefsky J: Effect of obesity on insulin resistance in normal subjects and patients with NIDDM. Diabetes 44:1121-1125, 1995 |
| 31. |
Kotzmann H, Linkesch M, Ludvik B, Clodi M, Luger A, Schernthaner G, Prager R, Klauser R: Effect of danazol-induced chronic hyperglucagonaemia on glucose tolerance and turnover. Eur.J.Clin.Invest 25:942-947, 1995 |
| 32. |
Thomaseth K, Kautzky-Willer A, Ludvik B, Prager R, Pacini G: Integrated mathematical model to assess beta-cell activity during the oral glucose test. Am.J.Physiol 270:E522-E531, 1996
 |
| 33. |
Kautzky-Willer A, Thomaseth K, Clodi M, Ludvik B, Waldhausl W, Prager R, Pacini G: Beta-cell activity and hepatic insulin extraction following dexamethasone administration in healthy subjects. Metabolism 45:486-491, 1996 |
| 34. |
Kautzky-Willer A, Thomaseth K, Ludvik B, Nowotny P, Rabensteiner D, Waldhausl W, Pacini G, Prager R: Elevated islet amyloid pancreatic polypeptide and proinsulin in lean gestational diabetes. Diabetes 46:607-614, 1997 |
| 35. |
Nolan JJ, Ludvik B, Baloga J, Reichart D, Olefsky JM: Mechanisms of the kinetic defect in insulin action in obesity and NIDDM. Diabetes 46:994-1000, 1997 |
| 36. |
Ludvik B, Kautzky-Willer A, Prager R, Thomaseth K, Pacini G: Amylin: history and overview. Diabet.Med. 14 Suppl 2:S9-13, 1997 |
| 37. |
Thomaseth K, Pacini G, Clodi M, Kautzky-Willer A, Nolan JJ, Prager R, Olefsky JM, Ludvik B: Amylin release during oral glucose tolerance test. Diabet.Med. 14 Suppl 2:S29-S34, 1997 |
| 38. |
Ludvik B: [Amylin/IAPP (islet amyloid polypeptide)--physiology and clinical significance]. Wien.Klin.Wochenschr. 109:379-383, 1997 |
| 39. |
Kautzky-Willer A, Prager R, Waldhausl W, Pacini G, Thomaseth K, Wagner OF, Ulm M, Streli C, Ludvik B: Pronounced insulin resistance and inadequate beta-cell secretion characterize lean gestational diabetes during and after pregnancy. Diabetes Care 20:1717-1723, 1997 |
| 40. |
Ludvik B, Nolan JJ, Roberts A, Baloga J, Joyce M, Bell JM, Olefsky JM: Evidence for decreased splanchnic glucose uptake after oral glucose administration in non-insulin-dependent diabetes mellitus. J.Clin.Invest 100:2354-2361, 1997
|
| 41. |
Ludvik B: [Weight loss by increasing energy consumption and thermogenesis]. Acta Med.Austriaca 25:136-137, 1998 |
| 42. |
Clodi M, Thomaseth K, Pacini G, Hermann K, Kautzky-Willer A, Waldhusl W, Prager R, Ludvik B: Distribution and kinetics of amylin in humans. Am.J.Physiol 274:E903-E908, 1998
|
| 43. |
Ludvik B: [Diabetes therapy related to etiology. Indications, uses and side effects of new insulin sensitizers]. MMW.Fortschr.Med. 142:27-28, 2000 |
| 44. |
Riedl M, Ludvik B, Pacini G, Clodi M, Kotzmann H, Wagner O, Kautzky-Willer A, Prager R, Luger A: The increased insulin sensitivity in growth hormone-deficient adults is reduced by growth hormone replacement therapy. Eur.J.Clin.Invest 30:771-778, 2000
|
| 45. |
Kautzky-Willer A, Pacini G, Tura A, Bieglmayer C, Schneider B, Ludvik B, Prager R, Waldhausl W: Increased plasma leptin in gestational diabetes. Diabetologia 44:164-172, 2001
|
| 46. |
Mari A, Pacini G, Murphy E, Ludvik B, Nolan JJ: A model-based method for assessing insulin sensitivity from the oral glucose tolerance test. Diabetes Care 24:539-548, 2001
|
| 47. |
Tura A, Ludvik B, Nolan JJ, Pacini G, Thomaseth K: Insulin and C-peptide secretion and kinetics in humans: direct and model-based measurements during OGTT. Am.J.Physiol Endocrinol.Metab 281:E966-E974, 2001
|
| 48. |
Ludvik B, Mahdjoobian K, Waldhaeusl W, Hofer A, Prager R, Kautzky-Willer A, Pacini G: The effect of Ipomoea batatas (Caiapo) on glucose metabolism and serum cholesterol in patients with type 2 diabetes: a randomized study. Diabetes Care 25:239-40, 2002
|
| 49. |
Georg P, Kautzky-Willer A, Mahdjoobian K, Hofer A, Prager R, Pacini G, Ludvik B: Influence of metabolic control on splanchnic glucose uptale, insulin sensitivity, and the time required for glucose absorption in patients with type 1 diabetes. Diabetes Care 25:2042-2047, 2002
|
| 50. |
Ludvik B, Thomaseth K, Nolan JJ, Clodi M, Prager R, Pacini G: Inverse relation between amylin and glucagon secretion in healthy and diabetic human subjects. Eur J Clin Invest 33:316-322, 2003
|
| 51. |
Tura A, Pacini G, Kautzky-Willer A, Ludvik B, Prager R, Thomaseth K: Basal and dynamic proinsulin-insulin relationship to assess {beta}-cell function during OGTT in metabolic disorders. Am J Physiol Endocrinol Metabol 285:E155-E162, 2003
|
| 52. |
Ludvik B, Waldhaeusl W, Prager R, Kautzky-Willer A, Pacini G: Mode of Action of Ipomoea batatas (Caiapo) in type 2 diabetic patients. Metabolism 52:875-880, 2003
|
| 53. |
Pichler B, Ludvik B: Future perspectives of pharmacotherapy of obesity. Journal für Kardiologie 10:427-429, 2003
|
| 54. |
Ludvik B, Neuffer B, Pacini G: Efficacy of Ipomoea batatas (Caiapo) on diabetes control in type 2 diabetic patients. Diabetes Care 27:436-440, 2004
|
| 55. |
Schindler K, Prager G, Ballaban T, Kretschmer S, Riener R, Buranyi B, Maier C, Luger A, Ludvik B: The Impact of Laparoscopic Adjustable Gastric Banding (LABG) on Plasma Ghrelin, Eating Behaviour and Body Weight. European Journal of Clinical Investigation 34:549-554, 2004
|
| 56. |
Schindler K, Ludvik B: Methodische und praktische Aspekte der Bestimmung der Körperzusammensetzung [Assessment of Body Composition - methods and practical aspects]. Wien Med Wochenschr 154(13-14):305-12, 2004
|
| 57. |
Tripp B, Ludvik B: Medikamentöse Therapie der Adipositas [Pharmacotherapy of Obesity]. Wien Med Wochenschr 154(13-14):320-8, 2004
|
| 58. |
Bohdjalian A, Langer FB, Hoda A, Felberbauer FX , Silberhumer G, Zacherl J, Schindler K, Luger A, Ludvik B, Prager G: Chirurgische Therapie der Adipositas. Wien Med Wochenschr 154(13-14):329-33, 2004
|
| 59. |
Tripp B, Ludvik B: Neue Antiadiposita [Novel Anti-Obesity-Drugs]. Acta Medica Austriaca 31(4):133-138, 2004
|
| 60. |
Cauza E, Hanusch-Enserer U, Strasser B, Ludvik B, Metz-Schimmerl S, Pacini G, Wagner O, Georg P, Prager R, Kostner K, Dunky A, Haber P: The Relative Benefits of Endurance and Strength Training on the Metabolic Factors and Muscle Function of People with Type 2 Diabetes Mellitus. Arch Phys Med Rehabil 86(8):1527-33, 2005
|
| 61. |
Langer FB, Reza Hoda MA, Bohdjalian A, Felberbauer FX, Zacherl J, Wenzl E, Schindler K, Luger A, Ludvik B, Prager G: Sleeve Gastrectomy and Gastric Banding: Effects on Plasma Ghrelin Levels. Obes Surg 15(7):1024-9, 2005
|
| 62. |
Cauza E, Hanusch-Enserer U, Strasser B, Ludvik B, Kostner K, Dunky A, Haber P: Continuous Glucose Monitoring in Diabetic Long Distance Runners. Int J Sports Med 26(9):774-80, 2005
|
| 63. |
Abrahamian H, Ludvik B, Schernthaner G, Prager R, Zellenka U, Knudsen L, Wascher T: Improvement of glucose tolerance in type 2 diabetic patients: traditional vs. modern insulin regimens (results from the Austrian Biaspart Study). Horm Metab Res 37(11):684-9, 2005
|
| 64. |
Haider DG, Schindler K, Schaller G, Prager G, Wolzt M, Ludvik B: Increased plasma visfatin concentrations in morbidly obese subjects are reduced after gastric banding. J Clin Endocrinol Metab. 91(4):1578-81, 2006
|
| 65. |
Langer FB, Bohdjalian A, Felberbauer FX, Fleischmann E, Reza Hoda MA, Ludvik B, Zacherl J, Jakesz R, Prager G: Does gastric dilatation limit the success of sleeve gastrectomy as a sole operation for morbid obesity? Obes Surg 16 (2):166-71, 2006
|
| 66. |
Bohdjalian A, Prager G, Aviv R, Policker S, Schindler K, Kretschmer S, Riener R, Zacherl J, Ludvik B: One year experience with Tantalus™: a New Surgical Approach to Treat Morbid Obesity. Obes Surg 16(5):627-34, 2006
|
| 67. |
Kautzky-Willer A, Tura A, Winzer C, Wagner OF, Ludvik B, Hanusch-Enserer U, Prager R, Pacini G: Insulin sensitivity during oral glucose tolerance test and its relations to parameters of glucose metabolism and endothelial function in type 2 diabetic subjects under metformin and thiazolidinedione. Diabetes Obes Metab 8(5):561-7, 2006
|
| 68. |
Schindler K, Haider D, Wolzt M , Rieger A, Gmeinhart B, Luger A, Nowotny P, Ludvik B: Impact of Antiretroviral Therapy on Visfatin and Retinol Binding Protein 4 in HIV+ Subjects. Eur J Clin Invest 36(9):640-6, 2006
|
| 69. |
Riener R, Schindler K, Ludvik B: Psychosocial Variables, Eating Behavior, Depression and Binge Eating in Morbidly Obese Subjects. Eating Behaviors 7(4):309-14, 2006
|
| 70. |
Dorner T, Fodor JG, Lawrence K, Ludvik B, Rieder A: HDL-knowledge in the lay public: results of a representative population survey. Atherosclerosis 195(1):195-8, 2007
|
| 71. |
Haider DG, Schindler K, Prager G, Bohdjalian A, Luger A, Wolzt M, Ludvik B: Serum retinolbinding protein 4 is reduced after weight loss in morbidly obese subjects. J Clin Endocrinol Metab 92(3):1168-71, 2007
|
| 72. |
Haider DG, Schindler K, Mittermayer F, Müller M, Nowotny P, Rieger A, Ludvik B, Wolzt M: Effect of rosiglitazone on visfatin and retinol binding protein-4 plasma concentrations in HIV-positive patients. Clin Pharmacol Ther 81(4):580-5 , 2007
|
| 73. |
Haider DG, Schindler K, Bohdjalian A, Prager G, Luger A, Wolzt M, Ludvik B: Plasma adipocyte and epidermal fatty acid binding protein is reduced after weight loss in obesity. Diabetes Obes Metab 9(5):761-3, 2007
|
| 74. |
Tripp B, Ludvik B: Antihypertensive and metabolic effects of telmisartan in patients with the metabolic syndrome in primary care--a field study. Wien Med Wochenschr 157(9-10):223-7, 2007 [German]
|
| 75. |
Anderwald C, Anderwald-Stadler M, Promintzer M, Prager G, Mandl M, Nowotny P, Bischof MG, Wolzt M, Ludvik B, Kästenbauer T, Pacini G, Luger A, Krebs M: The Clamp-Like Index: a novel and highly sensitive insulin sensitivity index to calculate hyperinsulinemic clamp glucose infusion rates from oral glucose tolerance tests in nondiabetic subjects. Diabetes Care 30(9):2374-80, 2007
|
| 76. |
Vila G, Maier C, Riedl M, Nowotny P, Ludvik B, Luger A, Clodi M: Bacterial endotoxin induces biphasic changes in plasma ghrelin in healthy humans. J Clin Endocrinol Metab 92(10):3930-4, 2007
|
| 77. |
Kollmann A, Riedl M, Kastner P, Schreier G, Ludvik B: Feasibility of a mobile phone-based data service for functional insulin treatment of type 1 diabetes mellitus patients. J Med Internet Res 9(5):e36, 2007
|
| 78. |
Ludvik B, Hanefeld M, Pacini G: Improved Metabolic Control by Ipomoea (Caiapo) is Associated with Increased Adiponectin and Decreased High Sensitive C-reactive Protein and Fibrinogen Levels in type 2 diabetic subjects. Diabetes Obes Metab 10(7):586-92, 2008
|
| 79. |
Kiefer FW, Zeyda M, Todoric J, Huber J, Geyeregger R, Weichhart T, Aszmann O, Ludvik B, Silberhumer GR, Prager G, Stulnig TM: Osteopontin expression in human and murine obesity: extensive local up-regulation in adipose tissue but minimal systemic alterations. Endocrinology 149(3):1350-7, 2008
|
| 80. |
Riedl M, Vila G, Maier C, Handisurya A, Shakeri-Manesch S, Prager G, Wagner O, Kautzky-Willer A, Ludvik B, Clodi M, Luger A: Plasma osteopontin increases after bariatric surgery and correlates with markers of bone turnover but not with insulin resistance. J Clin Endocrinol Metab 93(6):2307-12, 2008
|
| 81. |
Morak J, Schindler K, Goerzer E, Kastner P, Toplak H, Ludvik B, Schreier G: A pilot study of mobile phone-based therapy for obese patients. J Telemed Telecare 14(3):147-9, 2008
|
| 82. |
Langer FB, Bohdjalian A, Shakeri-Manesch S, Felberbauer FX, Ludvik B, Zacherl J, Prager G: Inadequate Weight Loss vs Secondary Weight Regain: Laparoscopic Conversion from Gastric Banding to Roux-en-Y Gastric Bypass. Obes Surg 18(11):1381-6, 2008
|
| 83. |
Brema I, Hatunic M, Finucane F, Burns N, Nolan JJ, Haider D, Wolzt M, Ludvik B: Plasma visfatin is reduced after aerobic exercise in early onset type 2 diabetes mellitus. Diabetes Obes Metab 10(7):600-2, 2008
|
| 84. |
Huber J, Kiefer FW, Zeyda M, Ludvik B, Silberhumer GR, Prager G, Zlabinger GJ, Stulnig TM: CC chemokine and CC chemokine receptor profiles in visceral and subcutaneous adipose tissue are altered in human obesity. J Clin Endocrinol Metab 93(8):3215-21, 2008
|
| 85. |
Maier C, Riedl M, Vila G, Nowotny P, Wolzt M, Clodi M, Ludvik B, Luger A: Cholinergic regulation of ghrelin and PYY release may be impaired in obesity. Diabetes 57(9):2332-40, 2008
|
| 86. |
Bohdjalian A, Ludvik B, Guerci B, Bresler L, Renard E, Nocca D, Karnieli E, Assalia A, Prager R, Prager: Improvement in glycemic control by
gastric electrical stimulation (TANTALUS(TM)) in overweight subjects with type 2 diabetes. G.Surg Endosc, 2008, [Epub ahead of print]
|
| 87. |
Vila G, Riedl M, Maier C, Struck J, Morgenthaler NG, Handisurya A, Prager G, Ludvik B, Clodi M, Luger A: Plasma MR-proADM Correlates to BMI and Decreases in Relation to Leptin After Gastric Bypass Surgery. Obesity (Silver Spring), 2009, [Epub ahead of print]
|
| 88. |
Schindler K, Rieger A, Tura A, Gmeinhardt B, Touzeau-Römer V, Haider D, Pacini G, Ludvik B: The Effect of Rosiglitazone on Insulin Sensitivity, Beta Cell Function, Bone Mineral Density, and Body Composition in HIV-positive Patients on Highly-active Antiretroviral Therapy (HAART). Horm Metab Res, 2009, [Epub ahead of print]
|
BUCHBEITRÄGE
|
| 1. |
Weissel M, Punzengruber C, Hartter E, Burghuber OC, Ludvik B, Woloszczuk W: Effect of treatment with L-thyroxine on plansma ANP levels in athyreotic patients: indirect evidence for the necessity of adequate thyroid hormone levels to maintain normal ANP levels. In Advances in atrial peptide research. Vol 2 ed. Brenner BM, Saragh JH, Eds. 1988, p. 293-297 |
| 2. |
Graf H, Watzinger U, Ludvik B, Wagner A, Höcker B, Zweymuller KK: Eigenblutspende unter Erythropoietin – ein neues Konzept für elektive orthopädische Eingriffe. In 10 Jahre Zweymüller Hüftendoprothese. Zweymuller KK, Ed. 1990, p. 77-81 |
| 3. |
Kautzky-Willer A, Capek M, Pacini G, Ludvik B, Prager R: Insulin secretion, insulin sensitivity and hepatic insulin extraction in essential hypertension. In Current Topics in Diabetes Research. Karger Verlag, 1993, p. 250-253 |
| 4. |
Ludvik B: Adipositas – Diagnostik und Therapie. In Ernährungsmedizin. Widhalm K, Diallo-Ginstl E, Eds. ÖAK 2000, 334-346 |
| 5. |
Ludvik B: Konservative Therapie der morbiden Adipositas. In Morbide Adipositas – Klinik und Therapie. Hell E, Miller K, Eds. Ecomed 2000, 20-25 |
| 6. |
Ludvik B: Sekundäre Diabetesformen. In Diabetes in der Praxis. Waldhaeusl W, Gries FA, Scherbaum W, Eds. Springer Verlag Berlin 2004 |
| 7. |
Ludvik B: Diabetes mellitus: ein progerones Krankheitsbild. Therapie, Prävention und Einfluss von Lifestyle. In Angewandte Anti-Aging-Medizin. Gasser R (Hg). Verlagshaus der Ärzte 2004 |
BÜCHER
|
| 1. |
Ludvik B (Ed): Risikofaktor Diabetes – Konzepte für ein Langzeitproblem. Uni-Med-Verlag Bremen, 1.Aufl. 2004 [ISBN: 3-89599-824-9]
 |
| 2. |
Ludvik B, Toplak H: Medikamentöse Therapie der Adipositas. Springer Verlag Wien, 1.Aufl. 2006 [ISBN: 3-211-83815-5]
|
| 3. |
Mihaljevic K, Feffer S, Ludvik B: Essen mit Spass + Aktivsein mit Mass. So entkommen Sie dem Metabolischen Syndrom. Verlagshaus der Ärzte, 1.Aufl. 2006 [ISBN: 3-901488-75-8]
|
| 4. |
Pfeiffer A, Ludvik B, Kinzl J: Für immer dünn. Was Ärzte wirklich empfehlen. CD. Galila Hörbuchverlag. 1.Aufl. 2006 [ISBN: 3-902533-01-3]
|
| 5. |
Prager R, Abrahamian H, Kautzky-Willer A, Ludvik B, Schütz-Fuhrmann I, Weitgasser R: Diabetesmanagement mit Insulinanaloga. UNI-MED Verlag AG, 1. Auflage, 2008 [ISBN 978-3-89599-919-2]
|
|
|
|
Original- und Übersichtsarbeiten
